3645 results for «569»
3645 results
Managing complications in STEMI: always possible?
20 May 2026 – From EuroPCR 2026
This session delves into the complexities of managing complications during STEMI interventions. Through real-world cases from Algeria, Malaysia, and Pakistan, it provides comprehensive analyses of challenging scenarios, treatment strategies, and key learnings, emphasizing the critical decision-making required to navigate complications and improve patient outcomes in high-stakes...
The dark side of calcium: complications, crashes and comebacks
20 May 2026 – From EuroPCR 2026
Focused on the formidable challenges posed by coronary calcium, this session presents three compelling cases illustrating complications, procedural crashes, and successful recoveries. Participants learn detailed approaches to treating PCI complications related to calcified lesions and develop a skillset aimed at prevention and effective management of these...
When calcium fights back: multinational insights into complex PCI and complication rescue
20 May 2026 – From EuroPCR 2026
This multinational session highlights advanced approaches to complex PCI involving heavily calcified coronary arteries. It aims to enhance mastery of contemporary calcium modification tools, reinforce decision-making skills in high-risk, complication-prone interventions, and optimize imaging-guided assessment of coronary calcium through illustrative cases from Bulgaria, Romania, and Tunisia.
Coronary interventions: first-in-man and novel devices
20 May 2026 – From EuroPCR 2026
Explore pioneering advancements in coronary interventions with first-in-man and novel devices. This session presents groundbreaking studies including cryotherapy for vulnerable plaques, a novel intravascular crossing system for coronary CTOs, sirolimus-coated retrievable scaffold therapy for in-stent restenosis, real-time intravascular photoacoustic imaging of lipid-rich plaques, and the inaugural...
OPTIMUM: Outcomes of Percutaneous RevascularizaTIon for Management of SUrgically Ineligible Patients with Multivessel or Left Main Coronary Artery Disease
04 Nov 2021
Mirvat Alasnag reviews the OPTIMUM trial, presented by David E. Kandzari, which reports outcomes in a subset of patients who are increasingly seen in modern day catheterization laboratories. It is noteworthy that 1 in 5 patients with left main or multivessel disease are considered surgically ineligible.
Author
